Official Journal of the Human Genome Organisation
Polymorphism | Control | Patients | DPN | DPWN | DPH | DPWH | |
---|---|---|---|---|---|---|---|
(CA) n | Allele | 2n = 1,624 | 2n = 2,080 | 2n = 236 | 2n = 530 | 2n = 818 | 2n = 264 |
(CA)11 | 96 (5.9) | 155 (7.4) | 15 (6.4) | 39 (7.3) | 62 (7.7) | 16 (6.1) | |
(CA)12 | 14 (0.9) | 27 (1.3) | 1 (0.4) | 3 (0.6) | 10 (1.2) | 2 (0.7) | |
(CA)13 | 304 (18.7) | 390 (18.8) | 41 (17.4) | 99 (18.7) | 164 (20.0) | 46 (17.4) | |
(CA)14 | 41 (2.5) | 41 (2.0) | 9 (3.8) | 7 (1.3) | 15 (1.8) | 8 (3.0) | |
(CA)15 | 885 (54.5) | 1,129 (54.3) | 128 (54.2) | 301 (56.8) | 436 (53.3) | 147 (55.7) | |
(CA)16 | 270 (16.6) | 314 (15.1) | 42 (17.8) | 79 (14.9) | 125 (15.3) | 44 (16.7) | |
(CA)17 | 14 (0.9) | 24 (1.1) | 0 (0.0) | 2 (0.4) | 6 (0.7) | 1 (0.4) | |
OR (95% CI)* | 1.01 (0.88–1.15) | 0.90 (0.66–1.23) | 0.90 (0.68–1.19) | ||||
P value | 0.92 | 0.56 | 0.51 | ||||
rs1061622 | MAF, G | 25.6 | 27.7 | 26.4 | 26.0 | 28.0 | 25.4 |
Genotype | n = 812 | n = 1,026 | n = 106 | n = 265 | n = 409 | n = 130 | |
GG | 47 (5.8) | 76 (7.4) | 4 (3.8) | 19 (7.2) | 33 (8.1) | 8 (6.1) | |
GT | 321 (39.5) | 417 (40.6) | 48 (45.3) | 100 (37.7) | 163 (39.8) | 50 (38.5) | |
TT | 444 (54.7) | 533 (51.9) | 54 (50.9) | 146 (55.1) | 213 (52.1) | 72 (55.4) | |
OR (95% CI)** | 1.12 (0.93–1.34) | 1.18 (0.75–1.85) | 1.14 (0.77–1.70) | ||||
P value | 0.25 | 0.54 | 0.58 | ||||
rs3397 | MAF, T | 42.3 | 41.3 | 38.6 | 40.0 | 41.4 | 39.7 |
Genotype | n = 813 | n = 1,030 | n = 110 | n = 265 | n = 412 | n = 131 | |
TT | 138 (17.0) | 167 (16.2) | 10 (9.1) | 43 (16.2) | 66 (16.0) | 19 (14.5) | |
CT | 412 (50.7) | 516 (50.1) | 65 (59.1) | 126 (47.6) | 209 (50.7) | 66 (50.4) | |
CC | 263 (32.3) | 347 (33.7) | 35 (31.8) | 96 (36.2) | 137 (33.3) | 46 (35.1) | |
OR (95% CI)** | 1.06 (0.87–1.29) | 1.22 (0.75–1.95) | 1.09 (0.72–1.64) | ||||
P value | 0.61 | 0.49 | 0.77 |